Condition
B-Cell Neoplasm clinical trials and research
As of November 12, 2026, Find a Trial lists 2 B-Cell Neoplasm clinical trials that are recruiting, at sites in 5 countries (most in United States (1), France (1), Germany (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
Zamtocabtagene autoleucel (MB-CART2019.1) for children and teens with relapsed or refractory mature B‑cell cancers
This study will try one fresh infusion of MB-CART2019.1, a tandem CD20‑CD19 CAR‑T treatment, in children and adolescents (6 months to under 18 years) whose mature B‑cell cancers have come back or not responded to prior therapy.
-
Combining Pomalidomide with Chemotherapy for HIV-Related Lymphomas
This study is testing if adding a drug called pomalidomide to chemotherapy can help adults with HIV-related lymphomas feel better and improve their treatment outcomes.
Related topics
Quick answers
How many B-Cell Neoplasm clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (1 trial), France (1 trial), Germany (1 trial), Italy (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.